Skip to main content
ICCM
NASDAQ Industrial Applications And Services

Court Certifies Class Action Lawsuit Against IceCure Medical, Officers, and Directors

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.279
Mkt Cap
$18.272M
52W Low
$0.253
52W High
$1.4
52W Position info
10% above low
Off High info
80% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ICCM is trading near its 52-week low of $0.253 (10% above the low).

Summary

A Tel Aviv District Court has approved a motion to certify a class action lawsuit against IceCure Medical, its officers, and directors, alleging issues with a 2021 private placement.


Key Events · Legal and Risk Events · ICCM

  • Class Action Certified

    On May 5, 2026, the Tel Aviv District Court approved a motion to certify a class action lawsuit against IceCure Medical, its officers, directors, and controlling shareholder.

  • Allegations of Improper Private Placement

    The lawsuit alleges that a private placement conducted in March 2021 was at a significant discount, did not reflect material information, and had defects in its approval process.

  • Company Disagrees and Plans Defense

    IceCure Medical disagrees with the court's decision, believes the claims are without merit, and intends to vigorously defend itself, including considering a motion for rehearing or further review.


Analysis · ICCM · Industrial Applications And Services

The court's decision to certify the class action significantly escalates the legal risk for IceCure Medical. While the company intends to vigorously defend itself, this development means the lawsuit can proceed with a broader group of plaintiffs, potentially increasing legal costs and the magnitude of any future settlement or judgment. The allegations concern a 2021 private placement, claiming it was conducted at a significant discount and lacked proper disclosure, which could impact investor confidence and future capital-raising efforts for this nano-cap company.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ICCM was trading at $0.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $18.3M. The 52-week trading range was $0.25 to $1.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ICCM - Latest Insights

ICCM
Nov 02, 2026, 4:50 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8428
Real-time Price: $0.7154 info
Change: -$0.1274 (-15%) info
Market Cap: $2.502M info
ICCM
Oct 05, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $0.7154 info
Change: -$0.8846 (-55%) info
Market Cap: $2.502M info
ICCM
Sep 10, 2026, 8:59 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $2.08
Real-time Price: $0.7154 info
Change: -$1.36 (-66%) info
Market Cap: $2.502M info
ICCM
Sep 10, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $0.7154 info
Change: -$1.40 (-66%) info
Market Cap: $2.502M info
ICCM
Aug 24, 2026, 7:50 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.48
Real-time Price: $0.7154 info
Change: -$1.76 (-71%) info
Market Cap: $2.502M info